Parenteral anticoagulation in ambulatory patients with cancer.

Authors: Akl EA, Kahale LA, Hakoum MB, Matar CF, Sperati F, Barba M, Yosuico VED, Terrenato I, Synnot A, Sch√ľnemann H.

Source: Cochrane Database of Systematic Reviews 2017, Issue 9. Art. No.: CD006652. DOI: 10.1002/14651858.CD006652.pub5.

Anticoagulation may improve survival in patients with cancer through a speculated anti-tumour effect, in addition to the antithrombotic effect, although may increase the risk of bleeding.

Objectives

To evaluate the efficacy and safety of parenteral anticoagulants in ambulatory patients with cancer who, typically, are undergoing chemotherapy, hormonal therapy, immunotherapy or radiotherapy, but otherwise have no standard therapeutic or prophylactic indication for anticoagulation.

Read Full Article

Select your region and press submit to request this article from your local library
Share this article
Share on FacebookTweet about this on TwitterShare on Google+Share on LinkedIn